Kim MK - Search Results

1

Application of plasma circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer.

Lee MR, Woo SM, Kim MK, Han SS, Park SJ, Lee WJ, Lee DE, Choi SI, Choi W, Yoon KA, Chun JW, Kim YH, Kong SY. Lee MR, et al. Among authors: kim yh, kim mk. Cancer Sci. 2024 Apr;115(4):1283-1295. doi: 10.1111/cas.16104. Epub 2024 Feb 13. Cancer Sci. 2024. PMID: 38348576 Free PMC article.

2

Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study.

Woo SM, Kim MK, Joo J, Yoon KA, Park B, Park SJ, Han SS, Lee JH, Hong EK, Kim YH, Moon H, Kong SY, Kim TH, Lee WJ. Woo SM, et al. Among authors: kim yh, kim th, kim mk. Cancer Res Treat. 2017 Oct;49(4):1022-1032. doi: 10.4143/crt.2016.495. Epub 2017 Jan 19. Cancer Res Treat. 2017. PMID: 28111423 Free PMC article.

3

Prognostic Implications of Multiplex Detection of KRAS Mutations in Cell-Free DNA from Patients with Pancreatic Ductal Adenocarcinoma.

Kim MK, Woo SM, Park B, Yoon KA, Kim YH, Joo J, Lee WJ, Han SS, Park SJ, Kong SY. Kim MK, et al. Among authors: kim yh. Clin Chem. 2018 Apr;64(4):726-734. doi: 10.1373/clinchem.2017.283721. Epub 2018 Jan 19. Clin Chem. 2018. PMID: 29352043

4

Phase I/II clinical trial of everolimus combined with gemcitabine/cisplatin for metastatic triple-negative breast cancer.

Park IH, Kong SY, Kwon Y, Kim MK, Sim SH, Joo J, Lee KS. Park IH, et al. Among authors: kim mk. J Cancer. 2018 Mar 8;9(7):1145-1151. doi: 10.7150/jca.24035. eCollection 2018. J Cancer. 2018. PMID: 29675095 Free PMC article.

5

Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.

Park C, Yoon KA, Kim J, Park IH, Park SJ, Kim MK, Jang W, Cho SY, Park B, Kong SY, Lee ES. Park C, et al. Among authors: kim j, kim mk. Cancer Sci. 2019 May;110(5):1760-1770. doi: 10.1111/cas.13982. Epub 2019 Apr 2. Cancer Sci. 2019. PMID: 30811755 Free PMC article.

6

Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib.

Oh CR, Kong SY, Im HS, Kim HJ, Kim MK, Yoon KA, Cho EH, Jang JH, Lee J, Kang J, Park SR, Ryoo BY. Oh CR, et al. Among authors: kim hj, kim mk. BMC Cancer. 2019 Apr 1;19(1):292. doi: 10.1186/s12885-019-5483-x. BMC Cancer. 2019. PMID: 30935424 Free PMC article.

7

Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples.

Choi SI, Jeon AR, Kim MK, Lee YS, Im JE, Koh JW, Han SS, Kong SY, Yoon KA, Koh YH, Lee JH, Lee WJ, Park SJ, Hong EK, Woo SM, Kim YH. Choi SI, et al. Among authors: kim yh, kim mk. Front Oncol. 2019 Sep 13;9:875. doi: 10.3389/fonc.2019.00875. eCollection 2019. Front Oncol. 2019. PMID: 31572675 Free PMC article.

8

Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer.

Ryu JS, Lee HY, Cho EH, Yoon KA, Kim MK, Joo J, Lee ES, Kang HS, Lee S, Lee DO, Lim MC, Kong SY. Ryu JS, et al. Among authors: kim mk. Cancer Sci. 2020 Oct;111(10):3912-3925. doi: 10.1111/cas.14600. Epub 2020 Sep 2. Cancer Sci. 2020. PMID: 32761968 Free PMC article.

9

Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study.

Woo SM, Kim MK, Park B, Cho EH, Lee TR, Ki CS, Yoon KA, Kim YH, Choi W, Kim DY, Hwang JH, Cho JH, Han SS, Lee WJ, Park SJ, Kong SY. Woo SM, et al. Among authors: kim yh, kim dy, kim mk. Cancers (Basel). 2021 Oct 30;13(21):5466. doi: 10.3390/cancers13215466. Cancers (Basel). 2021. PMID: 34771630 Free PMC article.

10

Targeted next generation sequencing of circulating tumor DNA provides prognostic information for management in breast cancer patients.

Shim H, Kwon MJ, Park IH, Kim MK, Cho EH, Lee J, Lee ST, Sim SH, Lee KS, Kim YH, Kim SK, Lee ES, Kong SY. Shim H, et al. Among authors: kim yh, kim sk, kim mk. Ann Transl Med. 2022 Jan;10(2):28. doi: 10.21037/atm-21-4881. Ann Transl Med. 2022. PMID: 35282050 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,397 results

Search Page